France
Tuberculosis profile
Population  2012 64 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.3 (0.28–0.31) 0.46 (0.44–0.49)
Mortality (HIV+TB only) 0.051 (0.037–0.071) 0.08 (0.06–0.11)
Prevalence  (includes HIV+TB) 7.4 (3.7–12) 12 (5.7–20)
Incidence  (includes HIV+TB) 5.3 (4.9–5.6) 8.2 (7.7–8.7)
Incidence (HIV+TB only) 0.37 (0.34–0.39) 0.57 (0.54–0.61)
Case detection, all forms (%) 89 (84–95)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 864 (33) Relapse 0 (0)
Smear-negative 910 (35) Treatment after failure 0 (0)
Smear-unknown / not done 122 (5) Treatment after default 0 (0)
Extrapulmonary 719 (27) Other 273 (100)
Other 7 (<1)      
Total new 2 622   Total retreatment 273  
           
Other (history unknown) 2 083        
Total new and relapse 2 622   Total cases notified 4 978  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.5 1.4 1.1
Age < 15 22 85 52
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive     Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary    
Retreatment    
TB/HIV 2012 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0.45 (0.24–0.77) 13 (7.4–21)
MDR-TB cases among notified pulmonary
TB cases
9 (5–15) 36 (20–58)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB      
Laboratory-confirmed MDR-TB cases     39
Patients started on MDR-TB treatment     39
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-24 Data: www.who.int/tb/data